Therefore, the aim of our study was to measure the alterations of plasma PACAP-38 like immunoreactivity (PACAP-38 LI) in acute and chronic HF caused by ischemic or non-ischemic cardiomyopathy compared to age-matched healthy controls. Here, ADCYAP1 is linked to ischemic cardiomyopathy.